The Connection Between Spirituality and Mental Health
Today, there are between 10,000 and 20,000 mental health apps. In the U.S. alone, there are 1.2 million mental health providers. And Mental Health Awareness Month began 75 years ago. It's safe to say we've never been more aware of mental health. And yet, some fear that as awareness of mental health has gone up, the state of our mental health has gone down.
A 2023 study found that one out of every two people in the world will develop a mental health disorder in their lifetime. The situation with young people is even worse. 'The youth mental health crisis is very real,' Dr. Harold Koplewicz, founding President and Medical Director of the Child Mind Institute, tells me. 'The most common disorders of childhood and adolescence are not infectious diseases but mental health disorders. Every 30 seconds a child or adolescent with suicidal ideation or an attempt comes to an ER.'
There are many reasons why these are particularly challenging times: Natural disasters are intensifying, chronic diseases continue to climb, and AI is driving fear and anxiety about all aspects of life. People are afraid they will lose their jobs to AI, that their kids will be negatively impacted by AI, and that AI's constantly accelerating development will evolve beyond human control.
But beyond the circumstances of the times we're living in lies a more complicated existential crisis.
As the French priest and philosopher Teilhard de Chardin once said, 'we are spiritual beings having a human experience.' When we give up on the spiritual part of human nature, we also give up on a supportive framework which can help us handle the anxieties of this historic moment of disruption.
Many answer this need for spirituality through organized religion, but as Columbia psychology professor Lisa Miller explains, there are many ways for people to embrace their spirituality. 'The moments of intense spiritual awareness were biologically identical whether or not they were explicitly religious, physiologically the same whether the experience occurred in a house of worship or on a forest hike in the 'cathedral of nature,'' she writes. 'Every single one of us has a spiritual part of the brain that we can engage anywhere, at any time.'
The exact practices we engage in that lead to spiritual states of mystery, awe, grace, and wonder doesn't matter. What does matter is that we don't amputate them from our lives.
The famed psychologist Abraham Maslow placed self-actualization at the top of his hierarchy of needs—above physiological needs, safety, and belonging. But in the last years of his life, he realized that self-actualization did not fully encompass what it means to be human and added 'transcendence' to the top of the pyramid.
As Maslow put it, 'The spiritual life is part of the human essence. It is a defining characteristic of human nature, without which human nature is not fully human.' It's this drive for spirituality that takes us beyond self-centeredness and allows us to resist despair and meaninglessness. This ability to find meaning in our struggles has helped humans navigate times of stress, turmoil, and crisis throughout history—and it is now validated by the latest science.
'When it comes to finding ways to help people deal with issues surrounding birth and death, morality and meaning, grief and loss, it would be strange if thousands of years of religious thought didn't have something to offer,' writes David DeSteno, author of How God Works: The Science Behind the Benefits of Religion.
Spirituality can help us not just weather times of crisis but even emerge stronger than before. A 2024 study on frontline healthcare workers in Poland during the pandemic found that higher levels of spirituality were connected to positive psychological change as the result of struggling with life challenges, known as post-traumatic growth.
According to Andrew Newberg, a neuroscientist at Thomas Jefferson University, the focused attention which occurs during spiritual practices like meditation and prayer can increase frontal lobe function, which governs executive control, and down-regulates the limbic system, which is linked to fear and the fight-or-flight response. 'When it comes to broader aspects of health, the improvements in brain function associated with spiritual practices that lead to reduced stress and anxiety ultimately can lead to benefits in physical health as well,' Newberg says.
'The practice of religion, as opposed to its theological underpinnings, offers an impressive, time-tested array of psychological technologies that augment our biology,' writes DeSteno. 'To ignore that body of knowledge is to slow the progress of science itself and limit its potential benefit to humanity.'
He describes religion first as working similar to how a a vaccine works, 'boosting the body's and the mind's resilience so that they can better confront whatever health challenges come their way.' And second, he uses the metaphor of medicine, healing the body and mind when sickness does hit. He cites a Mayo Clinic review of hundreds of studies in which a clear pattern emerged: 'people who regularly took part in religious activities were objectively healthier.'
Even more evidence has been provided by Miller through her work on MRI scans. 'The high-spiritual brain was healthier and more robust than the low-spiritual brain,' she writes. 'For spiritually aware people across faith traditions, the brain appeared able to protect itself from the long-standing neurological structures of depression.'
In what Miller calls our 'achieving awareness,' we're focused on organizing our lives, thinking about what we want and how to get it. This is how we build careers and get things done. But a life solely defined by achieving is an unballenced life. In our spiritual or 'awakened awareness,' our perception expands. We see ourselves not just as individual achievers but as connected to others. We seek and experience meaning and purpose. This is really the distinction between Maslow's self-actualization and self-transcendence.
In today's culture, many see therapy as the only answer to the mental and emotional struggles of modern life.
As psychiatrist Dr. Samantha Boardman writes: 'I am not anti-therapy. I am anti-therapy culture. I believe therapy works best when it is targeted and purposeful.' She is echoed by Dr. Richard Friedman, a psychiatrist at Weill Cornell Medicine, who wrote that 'excessive self-focus… can increase your anxiety, especially when it substitutes for tangible actions.' Excessive self-focus is exactly the sort of thing that can be mitigated in spiritual experiences connecting to something larger than ourselves.
The everyday behaviors Boardman cites that improve our mental well-being include practicing spirituality, spending time in nature, volunteering, and helping others.
A spiritual element, and an emphasis on helping others, have proven essential to the success of Alcoholics Anonymous. In co-founder Bill Wilson's book, Alcoholics Anonymous, published in 1939, he wrote that 'deep down in every man, woman, and child, is the fundamental idea of God. It may be obscured by calamity, by pomp, by worship of other things, but in some form or other it is there.'
Today, many people are hungry for a sense of spirituality. While religious affiliation has been dropping for decades, the spiritual impulse hasn't. A recent U.S. Gallup poll found that 82% consider themselves religious, spiritual, or both.
People have had valid reasons for leaving organized religion, but when we reject our innate predisposition for spirituality along with that, we deny ourselves the full, expansive possibilities of our humanity—as well as the tools to navigate the labyrinths of our lives.
Contact us at letters@time.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution
SOUTH SAN FRANCISCO, Calif., August 19, 2025--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity, in the life sciences segment of the health care sector, today launched the Twist Oncology DNA Comprehensive Genomic Profiling (CGP) Panel, a customizable, research-use-only solution designed to empower users to identify genomic alterations for a broad set of tumors, guide targeted therapy development and support clinical and translational oncology research. "We designed this panel to break the status quo in genomic profiling by offering laboratories a powerful alternative to locked, one-size-fits-all solutions," said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. "With our customizable content, flexible workflow, and compatibility with multiple sequencing platforms, Twist's Oncology DNA CGP Panel puts scientific control back in the hands of researchers and clinicians, particularly for those who need a more cost-effective solution compared to existing CGP products or a more efficient option than smaller panels." The Twist Oncology DNA CGP Panel was designed to serve a wide range of research groups including regional clinical labs, academic medical centers, and biopharma partners. The panel composition incorporates clinical research and includes a comprehensive and updated biomarker list covering 562 genes that incorporate all major tumor types. The panel's coverage spans genomic alterations and genomic signatures and can detect base substitutions, insertions and deletions (indels), copy number variations (CNVs), gene rearrangements as well as measure tumor mutational burden (TMB) and microsatellite instability (MSI). This is paired with Twist high quality and easy-to-use library preparation and target enrichment workflows. Twist is collaborating with several analytics companies to provide a complete solution from sequencing to analysis. About Twist Bioscience Corporation At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and defense, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts. Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis, sequencing and therapeutics discovery, providing both the quality and quantity of the tools they need to most rapidly realize the opportunity ahead. For more information about our products and services, please visit Follow us on LinkedIn | X | YouTube | Instagram | Bluesky Twist Bioscience Legal Notice Regarding Forward-Looking Statements This press release contains forward-looking statements. All statements other than statements of historical facts contained herein are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements about the expected future benefits and impact of the Twist Oncology DNA CGP Panel and collaborations with analytics companies. Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Twist's actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the ability to attract new customers and retain and grow sales from existing customers; the ability of Twist to achieve sufficient revenue to achieve or maintain positive cash flow from operations or profitability in any given period; ability to obtain financing when necessary; risks and uncertainties of rapidly changing technologies and extensive competition in synthetic biology that could make the products Twist is developing obsolete or non-competitive; ability to expand DNA synthesis manufacturing capacity; dependence on one supplier for a critical component; dependence on key personnel; additional regulations that could increase Twist's costs and delay commercialization efforts; changes in U.S. trade policies and other trade actions that could result in increased costs and supply chain disruptions; and the ability to maintain and enforce intellectual property protection. For a description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Twist's business in general, see Twist's risk factors set forth in Twist's Annual Report on Form 10-K for the year ended September 30, 2024 filed with the Securities and Exchange Commission (SEC) on November 18, 2024 and subsequent filings with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and Twist specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. View source version on Contacts For Investors: Angela BittingSVP, Corporate Affairs925-202-6211abitting@ For Media: Amanda HoulihanCommunications Manager774-265-5334ahoulihan@


Medscape
28 minutes ago
- Medscape
Air Pollution Exposure May Be Linked to Higher Asthma Risk
TOPLINE: Long-term exposure to ambient air pollutants over 48 months was associated with an increased risk for asthma exacerbation in women, even at low concentrations. Nitrogen dioxide (NO 2 ) showed the strongest association with higher odds of exacerbation. A plant-based diet did not modify these effects. METHODOLOGY: Researchers assessed the associations between 48-month air pollution exposure and asthma exacerbations in the Nurses' Health Study II cohort and examined whether a plant-based diet modifies these relationships. Overall, they analyzed 4326 women (mean age, 43 years; 96.7% White individuals) with physician-diagnosed asthma and medication use during 1997-1998 and 2013-2014 periods. Plant-based diet adherence was evaluated every 4 years using a validated food-frequency questionnaire that categorized intake into 18 groups (12 plant-based and six animal-based) and generated a Plant-Based Diet Index score ranging from 18 to 90. Residential exposures to fine particulate matter (PM 2.5 ), NO 2 , and ozone (O 3 ) were measured over 48-month periods before outcome assessments. ), NO , and ozone (O ) were measured over 48-month periods before outcome assessments. The main outcome was asthma exacerbation was defined as hospital admission, emergency department visits, or urgent care visits due to uncontrolled asthma in the past year, assessed in 1998 and 2014. TAKEAWAY: Median 48-month concentrations of PM 2.5 decreased from 13.7 μg/m 3 in 1993-1997 to 8.9 μg/m 3 in 2009-2013, and those of NO 2 dropped from 12.0 ppb to 6.6 ppb. However, median 48-month concentrations of ozone increased from 25.5 ppb to 27.8 ppb. decreased from 13.7 μg/m in 1993-1997 to 8.9 μg/m in 2009-2013, and those of NO dropped from 12.0 ppb to 6.6 ppb. However, median 48-month concentrations of ozone increased from 25.5 ppb to 27.8 ppb. In adjusted single-pollutant models, higher exposures to PM 2.5 and NO 2 were associated with increased odds of asthma exacerbation (adjusted odds ratio [aOR], 1.43; 95% CI, 1.14-1.80 and aOR, 1.25; 95% CI, 1.12-1.38, respectively). and NO were associated with increased odds of asthma exacerbation (adjusted odds ratio [aOR], 1.43; 95% CI, 1.14-1.80 and aOR, 1.25; 95% CI, 1.12-1.38, respectively). However, in adjusted multipollutant models, higher NO 2 exposure remained significantly associated with an increased risk for asthma exacerbation (aOR, 1.23; 95% CI, 1.06-1.42), whereas higher exposures to PM 2.5 and O 3 were not. exposure remained significantly associated with an increased risk for asthma exacerbation (aOR, 1.23; 95% CI, 1.06-1.42), whereas higher exposures to PM and O were not. No significant interaction was observed between air pollutants and plant-based diet index scores in relation to asthma exacerbation risk (P = .69 for PM 2.5 ; P = .29 for NO 2 ; P = .60 for O 3 ). IN PRACTICE: 'Our results add to growing evidence that supports lowering acceptable standards for key air pollutants and highlights the need to identify personal, modifiable strategies of increasing resilience among susceptible populations, including women with asthma,' the authors wrote. SOURCE: The study was led by Jing Gennie Wang, MD, Division of Pulmonary Critical Care and Sleep Medicine at The Ohio State University Wexner Medical Center in Columbus, Ohio. It was published online on July 28, 2025, in Annals of the American Thoracic Society. LIMITATIONS: The study population consisted predominantly of White female nurses, limiting generalizability. The Plant-Based Diet Index score could not distinguish between whole-food and ultraprocessed plant-based diets, potentially affecting the assessment of diet-pollution interactions. Residential mobility among participants may have introduced some exposure misclassification. DISCLOSURES: The study received funding from the Nurses' Health Study II cohort infrastructure grant and the American Lung Association Early Career Investigator Award. Most authors declared receiving grants from the American Lung Association, and two authors reported receiving financial support from some pharmaceutical organizations. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Forbes
30 minutes ago
- Forbes
AI Therapists Belong In The Back Office, Not The Chair.
Therapy has a supply problem. Depending on the dataset you pick, roughly half of U.S. adults with a mental illness don't receive treatment — a gap driven by cost, coverage and capacity. That unmet demand and with hopes of scalability is why AI therapists look irresistible to venture capital firms and patients alike — until you examine the safety risks. But new research from Stanford lands a simple warning label: proceed with caution. As a healthcare advisor, I see the damage when AI gives confident answers without a medical context. In a published case, a patient swapped table salt for sodium bromide on a chatbot's advice, developed bromide poisoning with psychosis, and recovered only after the hospital stopped the bromide. If you've been tracking the space, this isn't an academic quibble. On August 12, Illinois became the first state to ban AI for mental-health therapy unless licensed professionals are involved, joining recent restrictions in Nevada and Utah. Lawmakers are signaling two things: the risk is high and the marketing is overdone. What the Stanford team actually found Where AI does make sense today Used well, AI belongs behind the scenes — not in the therapist's chair. Keep it out of safety-critical clinical judgment and put it to work where it amplifies human care: handling intake, documentation, scheduling and billing so clinicians win back time for patients. In training, it can play the standardized patient to help clinicians rehearse difficult conversations and generate clean post-session summaries for supervision. And for the public, keep it to low-risk self-support — journaling prompts, CBT-style reflections and light coaching — wrapped in clear disclaimers and with instant handoffs to a human whenever risk appears. For employers, plans and investors: buy for assistive, not autonomous. When evaluating AI therapy chatbots or other mental-health AI, insist — in writing — on a clear clinical scope that spells out what the tool will and won't do, with a hard line at diagnosis, risk assessment, crisis navigation and treatment decisions. Require human-in-the-loop oversight for any feature that could touch risk, with escalation to licensed clinicians in seconds. Engineer safety by auditing for stigmatizing language, missed risk cues and hallucinations — and reward correct refusals and clean handoffs. Finally, market honestly: if it isn't clinician-supervised care, don't call it therapy. Regulators are watching. The bigger picture Real change in therapy happens inside a sustained, emotional human relationship. Progress often comes when a therapist survives your anger, withdrawal and tests and still leans in. A chatbot can simulate steadiness, but it can't be wounded, frustrated or changed by you. That makes AI a useful practice partner for skills — not the human bond that truly transforms people. Let AI clear the inbox so therapists can think, plan and see patients. And just as important, not get burned out. Machines do paperwork; humans do people-work. Therapy is about relationships, not a puzzle to be solved by logic and coding. Used thoughtfully, AI therapists amplify care; used poorly, they drift into roles only clinicians should play.